This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 11-14, 2026
Hynes Convention CenterBoston, MA

Neha Kaushal, Ph.D
Associate Director, Research and Biomarkers at Sanofi mRNA Center of Excellence
Speaker

Profile

Neha is an Associate Director within the Formulations and Delivery team at Sanofi's mRNA Center of Excellence (CoE). Prior to joining the CoE, she was part of the Translate Bio Team where she spearheaded the development of aerosolized mRNA-Lipid Nanoparticle (LNP) platform for protein replacement therapies targeting pulmonary diseases like Cystic Fibrosis, Pulmonary Ciliary Dyskinesia and more. Leveraging this core expertise at the mRNA CoE, she has driven the design and development of a novel intranasal mRNA LNP platform aimed at achieving critical mucosal immunity. Her focused scientific contributions center on the strategic design of new helper lipids to significantly improve the efficacy and thermostability of mRNA-LNP formulations across various applications, alongside leading efforts to develop targeted tissue-specific delivery strategies. She is a co-inventor on multiple issued patents and holds a Ph.D. in Biomedical Engineering from the University of Michigan.

Agenda Sessions

  • Beyond the Needle: Engineering Novel mRNA Lipid Nanoparticle Formulations for Mucosal Vaccination

    5:30pm